Vertex Pharmaceuticals Incorporated

BOVESPA:VRTX34 Stock Report

Market Cap: R$674.2b

Vertex Pharmaceuticals Future Growth

Future criteria checks 5/6

Vertex Pharmaceuticals is forecast to grow earnings and revenue by 47.4% and 8.7% per annum respectively. EPS is expected to grow by 47% per annum. Return on equity is forecast to be 30.6% in 3 years.

Key information

47.4%

Earnings growth rate

47.0%

EPS growth rate

Biotechs earnings growth31.6%
Revenue growth rate8.7%
Future return on equity30.6%
Analyst coverage

Good

Last updated22 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:VRTX34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202612,9244,9125,4605,87324
12/31/202511,8114,2824,7565,38833
12/31/202410,892-46851130731
9/30/202410,626-480-1,351-843N/A
6/30/202410,337-490-1,426-944N/A
3/31/202410,1854,0193,4793,944N/A
12/31/20239,8693,6203,2793,537N/A
9/30/20239,6543,4704,2054,381N/A
6/30/20239,5053,3653,8794,068N/A
3/31/20239,2083,2603,8904,074N/A
12/31/20228,9313,3223,9254,130N/A
9/30/20228,7013,2733,8144,047N/A
6/30/20228,3503,1953,7874,018N/A
3/31/20227,9482,4512,4512,679N/A
12/31/20217,5742,3422,4092,644N/A
9/30/20217,1302,1761,9192,140N/A
6/30/20216,6841,9921,7772,121N/A
3/31/20216,4152,7623,0483,359N/A
12/31/20206,2062,7122,9943,254N/A
9/30/20205,9912,6912,9793,208N/A
6/30/20205,4032,0812,5572,635N/A
3/31/20204,8191,5111,9832,060N/A
12/31/20194,1631,1771,4941,569N/A
9/30/20193,6202,1441,3631,438N/A
6/30/20193,4542,2151,4131,484N/A
3/31/20193,2652,1551,2581,342N/A
12/31/20183,0482,0961,1751,270N/A
9/30/20182,8296471,0601,183N/A
6/30/20182,623415N/A972N/A
3/31/20182,415226N/A832N/A
12/31/20172,489263N/A845N/A
9/30/20172,296196N/A762N/A
6/30/20172,131259N/A658N/A
3/31/20172,019177N/A517N/A
12/31/20161,702-112N/A236N/A
9/30/20161,661-219N/A121N/A
6/30/20161,557-275N/A-7N/A
3/31/20161,292-399N/A-158N/A
12/31/20151,032-556N/A-365N/A
9/30/2015759-659N/A-576N/A
6/30/2015628-734N/A-602N/A
3/31/2015600-704N/A-620N/A
12/31/2014580-738N/A-573N/A
9/30/2014787-582N/A-362N/A
6/30/2014830-530N/A-289N/A
3/31/20141,002-428N/A-162N/A
12/31/20131,212-504N/A-61N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VRTX34 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (10.4%).

Earnings vs Market: VRTX34 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: VRTX34 is expected to become profitable in the next 3 years.

Revenue vs Market: VRTX34's revenue (8.7% per year) is forecast to grow faster than the BR market (7.5% per year).

High Growth Revenue: VRTX34's revenue (8.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: VRTX34's Return on Equity is forecast to be high in 3 years time (30.6%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y